{
  "actions": [
    {
      "acted_at": "2023-09-26",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2023-09-26",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2023-09-29",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr5708-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "P000616",
      "district": "3",
      "name": "Phillips, Dean",
      "original_cosponsor": true,
      "sponsored_at": "2023-09-26",
      "state": "MN",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-09-26",
  "number": "5708",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "MCM PRV Reauthorization Act",
  "sponsor": {
    "bioguide_id": "F000475",
    "district": "1",
    "name": "Finstad, Brad",
    "state": "MN",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-09-26",
  "subjects": [
    "Chemical and biological weapons",
    "Health",
    "Health technology, devices, supplies",
    "Infectious and parasitic diseases",
    "Licensing and registrations",
    "Prescription drugs",
    "User charges and fees"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MCM PRV Reauthorization Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "MCM PRV Reauthorization Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.",
      "type": "official"
    }
  ],
  "updated_at": "2024-07-24T15:20:18Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr5708.xml"
}